PTAB Grants Narcan IP Review, Rejects Redundant Petitions
The Patent Trial and Appeal Board has agreed to review a patent covering the opioid overdose treatment Narcan, but turned away two other challenges to the same patent as part of...To view the full article, register now.
Already a subscriber? Click here to view full article